Condition
Infectious Endocarditis
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02252900Not ApplicableCompletedPrimary
Long-term Clinico-radiological Evolution of Patients With Brain Lesions During Infectious Endocarditis
NCT03681431Phase 2CompletedPrimary
Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis
NCT05530837CompletedPrimary
Characterization of Enterococcus Faecalis Endocarditis and Impact of Amoxicillin MIC Elevation on Patient Outcome
NCT04691440Phase 2UnknownPrimary
Hyperbaric Oxygen Treatment in Humans With Gram Positive Cocci Endocarditis
NCT03851575Not ApplicableUnknownPrimary
Accelerated Treatment of Endocarditis
Showing all 5 trials